Innomorph Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Punjagutta, Hyderabad,082, Telangana, India, established in 2004.
2004 Punjagutta, Hyderabad,082, Telangana, India Struck Off
Last Updated:
Access Report
About Innomorph Drugs Private Limited

Innomorph Drugs Private Limited, a struck off private limited company, was established on 11 November 2004 in Punjagutta, Hyderabad,082, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG2004PTC044602. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pavani Bommareddy (Director), Venkatram Reddy Pulagam (Director), Veera Venkata Siva Kumar Reddy Bommareddy (Director). Its latest AGM occurred on 28 April 2018, with the balance sheet filed on 31 March 2018. It is based at 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082, Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2004PTC044602

  • Registration Number

    044602

  • Incorporation Date

    11 November 2004

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** %
  • Profit Growth **** 34.09%
  • Ebitda **** 38.46%
  • Total Assets **** %
Company report

Innomorph Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Innomorph Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Innomorph Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Pavani Bommareddy Director 11 Nov 2004 Current
Venkatram Reddy Pulagam Director 01 Aug 2011 Current
Veera Venkata Siva Kumar Reddy Bommareddy Director 11 Nov 2004 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Innomorph Drugs.

Innomorph Drugs Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 34.09% increase in profit. The company's net worth witnessed no change by increase of 0%.

Innomorph Drugs revenue growth over time
Innomorph Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 34.09%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 38.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Innomorph Drugs?

In 2018, Innomorph Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Innomorph Drugs?

Unlock and access historical data on people associated with Innomorph Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Innomorph Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innomorph Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Innomorph Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Innomorph Drugs Private Limited last Annual general meeting of members was held on 28 Apr 2018 as per latest MCA records. was completed.

  • Balance Sheet

    Innomorph Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Venkatram Reddy Pulagam was appointed as a Director was appointed as a Director on 01 Aug 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Pavani Bommareddy was appointed as a Director was appointed as a Director on 11 Nov 2004 & has been associated with this company since 21 years 3 months . was documented.

  • Director Appointment

    Veera Venkata Siva Kumar Reddy Bommareddy was appointed as a Director was appointed as a Director on 11 Nov 2004 & has been associated with this company since 21 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Innomorph Drugs Private Limited was registered on 11 Nov 2004 with Roc Hyderabad & aged 21 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Innomorph Drugs Private Limited?

The CIN of Innomorph Drugs Private Limited is U24239TG2004PTC044602.

Where is Innomorph Drugs Private Limited headquartered?

Innomorph Drugs Private Limited is headquartered at 6-3-883/5. Venkat Plaza.Punjagutta, Hyderabad,082 Punjagutta, Hyderabad,082, Punjagutta, Hyderabad,082, Telangana.

When was Innomorph Drugs Private Limited incorporated?

Innomorph Drugs Private Limited was incorporated on 11 November 2004.

Who are the current directors of Innomorph Drugs Private Limited?

The current directors of Innomorph Drugs Private Limited are

What is the primary industry of Innomorph Drugs Private Limited?

The primary industry of Innomorph Drugs Private Limited is Chemicals.

Is Innomorph Drugs Private Limited a listed company?

Innomorph Drugs Private Limited is unlisted.

What is the capital structure of Innomorph Drugs Private Limited?

The authorized capital of Innomorph Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available